soul trial oral semaglutide cardiovascular outcomes results 2024 nejm The impact of on events in patients with type 2 diabetes: review of from the Semaglutide cardiovascular outcomes align more

Always inject at a 90-degree angle to avoid injecting into the muscle and prevent medication leakage

Compared with nonusers, adults taking GLP-1s had a: 17 percent lower risk of venous thromboembolism, or blood clots in the veins 31 percent lower risk of pulmonary embolism, a potentially life-threatening clot that travels to the lungs 21 percent lower risk of going to the emergency department 44 percent lower risk of all-cause mortality (death from any cause) Researchers also observed lower stroke rates among GLP-1 users, although this difference didnt reach statistical significance

As one of the industrys top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need

The trade-off is potency

En parallle, il a galement t constat que le statut en glutathion rduit se retrouvait li plusieurs processus associs la longvit